5RY-81424-56170
4 vaccinations
2 coded responses
15 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 41-45
- ZIP prefix
- 946 / CA
- Registered
- 2021-04-16
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-04-08
Dose 1 — Janssen/Johnson & Johnson
-
2021-04-16
Registered in v-safe
- 2021-04-16
- 2021-04-23
- 2021-04-29
- 2021-05-06
- 2021-05-13
- 2021-05-20
- 2021-07-08
-
2021-07-12
Dose 2 — Pfizer-BioNTech
-
2021-08-05
Dose 3 — Pfizer-BioNTech
- 2021-10-07
-
2022-04-08
Survey response — 12 months, dose 1MedDRA: Gastroenteritis viral — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: stomach fluMedDRA releases: 2024-11 · check-in free text available
-
2022-09-08
Dose 4 — Pfizer-BioNTech
- 2022-10-03
- 2022-10-06
- 2022-10-13
- 2022-10-20
- 2022-12-08
-
2023-03-09
Survey response — 6 months, dose 4MedDRA: Gastroenteritis viral, Nasopharyngitis — Feeling: FairMedDRA releases: 2024-11
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-08 | Janssen/Johnson & Johnson | |
| 2 | 2021-07-12 | Pfizer-BioNTech | No |
| 3 | 2021-08-05 | Pfizer-BioNTech | No |
| 4 | 2022-09-08 | Pfizer-BioNTech | No |
Free text
Release 11 — 12 months, dose 1
Symptoms: stomach flu
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Gastroenteritis viral | · | · | ✓ |
| SD | Nasopharyngitis | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release